AEROSIL® 200 Pharma

Description

AEROSIL® 200 Pharma is a high purity amorphous anhydrous colloidal silicon dioxide for use in pharmaceutical products which fulfils the analytical requirements of the currently valid versions of the European Pharmacopeia (Ph. Eur.), United States Pharmacopeia (USP/NF), Japanese Pharmacopeia (JP) and Indian Pharmacopoeia** (IP). It fulfils purity criteria of E551 according to 231/2012 EU.

Our manufacturing plants have implemented a system based on Good Manufacturing Practices and Hazard Analysis and Critical Control Points for food additives.
TAMC (total aerobic microbial count) and TYMC (total combined yeast and mould count) are tested on a regular basis acc. to USP.
**for Rheinfelden and Antwerp products only

Shelf Life: 2 years

• Hydrophilic fumed silica powder
• BET Surface area: 175 – 225 m2/g
• Key effects: free-flow, anti-caking, tablet hardness and friability, thixotropy
• Typical applications: pharma